Jamie Lynn Kimball, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Us Highway 61, New Madrid, MO 63869 Phone: 573-688-2161 |
Mrs. Sharon K Musgraves Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Us Highway 61, New Madrid, MO 63869 Phone: 573-688-2161 Fax: 573-688-2169 |
Melissa Nicole Eddy-sides Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Us Highway 61, New Madrid, MO 63869 Phone: 573-688-2161 Fax: 573-688-2169 |
Mrs. Charlotte Ann Hogan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Des Cyprie Pl, New Madrid, MO 63869 Phone: 573-748-5324 Fax: 573-748-8909 |
Elizabeth A Riley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Us Highway 61, New Madrid, MO 63869 Phone: 573-688-2161 Fax: 573-688-2169 |
Ms. Linda Lou Bell, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 955 Us Highway 61, New Madrid, MO 63869 Phone: 573-748-5568 |
News Archive
Morinaga Milk Industry Co., Ltd., a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT).
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
While for years scientists have noted an association between levels of vitamin D in a person's body and the person's ability to resist or minimize the effects of multiple sclerosis (MS), the mechanism involved has not been established.
A new study, conducted by researchers from the Regenstrief Institute and the schools of medicine at Indiana University and Moi University, is one of the first to explore and demonstrate the impact of electronic record systems on quality of medical care in a developing country.
For the first time, researchers have developed a genetically altered animal model for cystic fibrosis (CF) that closely matches the characteristics of the disease in humans. By studying the complex and multi-organ disease process in the pig model, researchers can now better understand how the complications of CF develop, an advancement that may lead to new avenues for research in prevention and treatment.
› Verified 2 days ago